1. AZGP1 suppresses epithelial-to-mesenchymal transition and hepatic carcinogenesis by blocking TGFβ1-ERK2 pathways. Issue 2 (1st May 2016) Authors: Xu, Ming-Yi; Chen, Rong; Yu, Jing-Xia; Liu, Ting; Qu, Ying; Lu, Lun-Gen Journal: Cancer letters Issue: Volume 374:Issue 2(2016) Page Start: 241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Diagnostic Performance of FibroTouch Ultrasound Attenuation Parameter and Liver Stiffness Measurement in Assessing Hepatic Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Issue 4 (13th April 2021) Authors: Qu, Ying; Song, Yan-Yan; Chen, Cheng-Wei; Fu, Qing-Chun; Shi, Jun-Ping; Xu, Yun; Xie, Qing; Yang, Yong-Feng; Zhou, Yong-Jian; Li, Liang-Ping; Xu, Ming-Yi; Cai, Xiao-Bo; Zhang, Qi-Di; Yu, Hao; Fan, Jian-Gao; Lu, Lun-Gen Journal: Clinical and translational gastroenterology Issue: Volume 12:Issue 4(2021) Page Start: e00323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Linc‐SCRG1 accelerates liver fibrosis by decreasing RNA‐binding protein tristetraprolin. Issue 2 (18th September 2018) Authors: Wu, Jun-Cheng; Luo, Sheng-Zheng; Liu, Ting; Lu, Lun-Gen; Xu, Ming-Yi Journal: FASEB journal Issue: Volume 33:Issue 2(2019) Page Start: 2105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗